Epidemiology and Prevention Approaches for Cytomegalovirus (CMV) Disease in CMV-Seropositive Kidney Transplant (KT) Recipients: Results from a Multicenter, Prospective, Cohort Study (OPERA Study)

被引：0
|
作者：
Aguado, J. [1 ]
Fernandez-Ruiz, M. [1 ]
Arias, M. [2 ]
Campistol, J. [3 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Hosp Univ Marques de Valdecilla, Santander, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [1] CYTOMEGALOVIRUS (CMV) PREVENTION STRATEGIES IN SEROPOSITIVE KIDNEY TRANSPLANT (KT) RECIPIENTS RECEIVING ANTILYMPHOCYTE INDUCTION THERAPIES: DATA FROM A MULTICENTER COHORT STUDY (THE OPERA STUDY)
    Aguado, Jose M.
    Fernandez-Ruiz, Mario
    Arias, Manuel
    Campistol, Josep M.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 29 - 29
  • [2] USE OF CYTOMEGALOVIRUS (CMV) HYPERIMMUNE GLOBULIN FOR PREVENTION OF CMV-DISEASE IN CMV-SEROPOSITIVE LUNG-TRANSPLANT RECIPIENTS
    ZAMORA, MR
    FULLERTON, DA
    CAMPBELL, DN
    LEONE, S
    DIERCKS, MJ
    FISHER, JH
    BADESCH, DB
    GROVER, FL
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 49 - 51
  • [3] Humoral Immunity Profiles to Identify CMV-seropositive Heart Recipients at Risk of CMV Disease: A Prospective Multicenter Study
    Sarmiento, E.
    Jaramillo, M.
    Navarro, J.
    Rodriguez-Molina, J.
    Fernandez-Yanez, J.
    Palomo, J.
    Gomez-Sanchez, M.
    Crespo-Leiro, M.
    Paniagua, M.
    Almenar, L.
    Cebrian, M.
    Segovia, J.
    Gomez, M.
    Rabago, G.
    Levy, B.
    Mirabet, S.
    Lopez, J.
    Garcia-Guereta, L.
    Carbone, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S20 - S20
  • [4] Impact of Different Prevention Strategies On the Risk of Cytomegalovirus (CMV) Infection and Disease in Seropositive Kidney Transplant (KT) Recipients
    Aguado, J.
    Fernandez-Ruiz, M.
    Arias, M.
    Campistol, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 765 - 766
  • [5] CMV prophylaxis with valganciclovir in CMV-seropositive kidney- and liver-transplant recipients:: A pilot study
    Weclawiack, Hugo
    Kamar, Nassim
    Mengelle, Catherine
    Guitard, Joelle
    Ribes, David
    Lavayssiere, Laurence
    Esposito, Laure
    Cointault, Olivier
    Durand, Dominique
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2007, 20 : 206 - 206
  • [6] Prospective Study on CMV-Reactivations Under Preemptive Strategy in CMV-Seropositive Adult Liver Transplant Recipients
    Lautenschlager, I
    Loginov, R.
    Makisalo, H.
    Hockerstedt, K.
    TRANSPLANTATION, 2012, 94 (10) : 34 - 34
  • [7] Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipients
    Lautenschlager, Irmeli
    Loginov, Raisa
    Makisalo, Heikki
    Hockerstedt, Krister
    JOURNAL OF CLINICAL VIROLOGY, 2013, 57 (01) : 50 - 53
  • [8] Impact of Different Prevention Strategies On the Risk of Cytomegalovirus (CMV) Infection and Disease in Seropositive Kidney Transplant (KT) Recipients.
    Aguado, J.
    Fernandez-Ruiz, M.
    Arias, M.
    Campistol, J.
    TRANSPLANTATION, 2014, 98 : 765 - 766
  • [9] Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors
    Seu, P
    Winston, DJ
    Holt, CD
    Kaldas, F
    Busuttil, RW
    TRANSPLANTATION, 1997, 64 (11) : 1614 - 1617
  • [10] Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
    McBride, Jacqueline M.
    Sheinson, Daniel
    Jiang, Jenny
    Lewin-Koh, Nicholas
    Werner, Barbara G.
    Chow, Jennifer K. L.
    Wu, Xiaoning
    Tavel, Jorge A.
    Snydman, David R.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (02):
12345